Recent News

Share
Print
and/or
540 News Items found
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer
The findings could pave the way toward more targeted treatments for the disease.
Event
GSK dean and graduates in their caps and gowns
MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners
At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
Gerstner Sloan Kettering Students
8 Gerstner Sloan Kettering Students Prepare To Graduate
Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
Dan Heller
A Sensor Sniffs for Cancer, Using Artificial Intelligence
By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
SKI immunologist Ming Li
SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
Charles Sawyers and Elizabeth Wasmuth
With CryoEM, MSK Researchers Obtain Exquisite View of the Androgen Receptor — A Key Protein in Prostate Cancer
The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center Announces The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.
Three women standing next to each other in a lobby
Celebrating the 3rd Annual Kravis WiSE Symposium at Memorial Sloan Kettering Cancer Center
The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WiSE fellowships.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions
Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.